Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements & Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements & Reports
Announcements & Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
24 Jun 2019
Dr John Lambert appointed as new CEO
17 Jun 2019
Preliminary Rights Issue Details
14 Jun 2019
Placement Cleansing Notice
14 Jun 2019
Appendix 3B - Placement $360k
12 Jun 2019
Capital Raising for Clinical-Enabling Studies
29 May 2019
Preliminary Final Report - Year Ended 31 March 2019
30 Apr 2019
Appendix 4C - Quarterly Statement of Cash Flows
01 Apr 2019
European Patent Completes IP Protection in Major Markets
11 Mar 2019
Amplia Expands Advisory Board
12 Feb 2019
Update - February 2019 Newsletter
Previous
1
2
3
4